Image 2021 10 06 T14 18 55


Blog Img

Jan Lichtenberg, CEO of InSphero AG - Mantell Associates Network Podcast

Episode 14 of this series of the Mantell Associates Network welcomes Jan Lichtenberg, CEO and Founder of InSphero AG.

In this episode Alessandro Mantell speaks with Jan Lichtenberg, who is an experienced company Founder, Chief Executive Officer, and Board Delegate with a 15 year track record in the Biotechnology industry. Jan has extensive experience in Preclinical testing both safety and discovery and with a proven track record of identifying promising technologies, matching them to customer pains and gains, and then rapidly maturing them into industry-grade solutions with a talented and motivated team. Jan’s vision is creating a world where new drugs can be developed accurately, efficiently and rapidly with a patient-centric focus using human 3D in-vitro cell models.

InSphero AGworks to advance drug discovery and understanding of healthy and diseased human biology using an inspired combination of bioengineering, microtechnologies, and computational approaches. They bring together an exceptional interdisciplinary team to create miniature organs and biological systems to better predict the patient response in vitro.

The aim of theMantell Associates Network Podcastis to connect people all around the world and empower people and businesses by sharing the stories, advice and outlook of influential leaders at market-leading companies across the industry. This podcasts provides exposure for the individuals and businesses currently doing great things, and works to unify the Pharmaceutical & Life Science industry. You can also listen to this podcast on the following streams:

Mantell Associates is a specialist Pharmaceutical and Life Sciences Recruitment organisation. To find out how we can help with your headhunting or recruitment needs, or if joining us on the podcast and sharing your experience with the rest of the Pharmaceutical & Life Science industry is something you’d be interested in doing, contact us on +44 (0)20 3854 7700.